glucagon has been researched along with Emesis in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (53.85) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| LeClair, LA; Senart, AM | 1 |
| Elbarsha, AM; Elmehdawi, RR | 1 |
| Beglinger, C; Fischer, H; Goeke, B; Kienle, P; Meyer-Gerspach, AC; Schirra, J; Schulte, F; Steinert, RE | 1 |
| Conceição, FL; Paixão, CM; Seixas-da-Silva, IA; Silvestre, DH; Tavares, AB; Vaisman, M | 1 |
| Awad, NI; Bridgeman, PJ; Cavallari, JM; Jawaro, TS | 1 |
| de la Peña, A; Fineman, M; Irie, S; Isaka, Y; Kothare, PA; Linnebjerg, H; Mace, K; Sakata, Y; Shigeta, H; Teng, CH; Uenaka, K; Yamamura, A; Yeo, KP | 1 |
| Baron, AD; Fineman, MS; Kim, DD; Kolterman, OG; Nielsen, LL; Ruggles, JA; Shen, L | 1 |
| Deacon, CF; Holst, JJ | 1 |
| El-Ouaghlidi, A; Nauck, MA | 1 |
| Attix, E; Stern, JS; Strombeck, DR; Wheeldon, EB | 1 |
| Billig, I; Rinaman, L; Yates, BJ | 1 |
| Adachi, K; Hashimoto, T; Hattori, S; Hirakawa, K; Ishimura, N; Katsube, T; Kinoshita, Y; Kurotani, A | 1 |
| Larsen, S; Myren, J; Qvigstad, T | 1 |
| Court, JM | 1 |
| Kidson, W | 1 |
| Larsen, S; Melsom, M; Moe, A; Myren, J | 1 |
| Hulse, EV; Patrick, G | 1 |
| Chernish, SM; Maglinte, DD | 1 |
| Bindi, M; Pepi, F; Pirtoli, L; Sebaste, L; Tucci, E | 1 |
| Gabriel, E; Küfferle, B | 1 |
| al-Samarrae, HM; Basu, PK; Daniel, O | 1 |
| Ulbrych-Jablońska, A | 1 |
| Bickel, H; Lutz, P; Nützenadel, W | 1 |
| Williams, JF | 1 |
| Fontanes, AL; Nord, HJ; Williams, JF | 1 |
| Danzig, R; Diamond, G; Forrester, J; Parmley, WW; Swan, HJ | 1 |
1 review(s) available for glucagon and Emesis
| Article | Year |
|---|---|
Glucagon and the cardiovascular system.
Topics: Blood Circulation; Cardiac Output; Cardiovascular System; Chronic Disease; Electrophysiology; Glucagon; Heart; Heart Failure; Humans; Muscle Contraction; Myocardium; Nausea; Sympathomimetics; Vascular Resistance; Vomiting | 1969 |
7 trial(s) available for glucagon and Emesis
| Article | Year |
|---|---|
Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
Topics: Adolescent; Adult; Appetite; Appetite Depressants; Cross-Over Studies; Double-Blind Method; Drinking Behavior; Energy Intake; Feeding Behavior; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Infusions, Intravenous; Male; Peptide Fragments; Peptide YY; Postprandial Period; Receptors, Glucagon; Up-Regulation; Vomiting; Young Adult | 2014 |
Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus.
Topics: Area Under Curve; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Exenatide; Female; Glucagon; Half-Life; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Japan; Male; Middle Aged; Nausea; Peptides; Single-Blind Method; Time Factors; Treatment Outcome; Venoms; Vomiting | 2008 |
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
Topics: Administration, Oral; Adolescent; Adult; Aged; Area Under Curve; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Exenatide; Female; Gastric Emptying; Glucagon; Humans; Injections, Subcutaneous; Insulin; Male; Middle Aged; Nausea; Peptides; Postprandial Period; Single-Blind Method; Venoms; Vomiting | 2005 |
Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy--a comparative study with butyl scopolamine bromide.
Topics: Aged; Blood Pressure; Butylscopolammonium Bromide; Endoscopy, Gastrointestinal; Female; Gastrointestinal Agents; Gastrointestinal Motility; Glucagon; Glucose; Heart Rate; Humans; Hypoglycemia; Male; Oxygen; Parasympatholytics; Prospective Studies; Vomiting | 2002 |
Comparison of glucagon, atropine, and placebo as premedication for endoscopy of the upper gastrointestinal tract.
Topics: Aged; Atropine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fiber Optic Technology; Gastroesophageal Reflux; Gastroscopy; Glucagon; Humans; Male; Middle Aged; Peristalsis; Placebos; Premedication; Pylorus; Vomiting | 1979 |
Comparison of glucagon and pethidine plus atropine as premedication for peroral endoscopy. A double blind study.
Topics: Aged; Atropine; Digestive System; Duodenum; Endoscopy; Gastric Juice; Gastrointestinal Motility; Glucagon; Humans; Male; Meperidine; Middle Aged; Mouth; Muscle Relaxation; Premedication; Saliva; Stomach; Vomiting | 1977 |
Treatment of congestive heart failure with glucagon.
Topics: Adult; Aged; Cardiac Catheterization; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Glucagon; Heart Failure; Humans; Male; Middle Aged; Nausea; Vomiting | 1970 |
18 other study(ies) available for glucagon and Emesis
| Article | Year |
|---|---|
Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker Toxicity: a Case Series.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Glucagon; Humans; Nausea; Retrospective Studies; Vomiting | 2023 |
An accidental liraglutide overdose: case report.
Topics: Accidents; Blood Glucose; Drug Overdose; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Liraglutide; Middle Aged; Nausea; Treatment Outcome; Vomiting | 2014 |
Potential risks of glucagon stimulation test in elderly people.
Topics: Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Female; Glucagon; Hormones; Human Growth Hormone; Humans; Hydrocortisone; Hypotension; Male; Nausea; Pituitary Diseases; Seizures; Severity of Illness Index; Sweating; Vomiting | 2015 |
Glucagon for refractory asthma exacerbation.
Topics: Administration, Intravenous; Adult; Albuterol, Ipratropium Drug Combination; Anti-Asthmatic Agents; Antiemetics; Asthma; Continuous Positive Airway Pressure; Disease Progression; Female; Glucagon; Hormones; Humans; Male; Middle Aged; Vomiting | 2017 |
Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glycoproteins; Homeostasis; Humans; Models, Biological; Nausea; Peptide Fragments; Protein Precursors; Vomiting | 2005 |
The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glycoproteins; Homeostasis; Humans; Nausea; Peptide Fragments; Protein Precursors; Vomiting | 2005 |
Effects of an anticholinergic and a corticosteroid on acute pancreatitis in experimental dogs.
Topics: Amylases; Animals; Atropine; Dexamethasone; Diarrhea; Dog Diseases; Dogs; Female; Glucagon; Insulin; Leukocytosis; Lipase; Male; Pancreas; Pancreatic Diseases; Pancreatitis; Vomiting | 1981 |
Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Brain Stem; Cell Count; Cholecystokinin; Dose-Response Relationship, Drug; Ferrets; Glucagon; Glucagon-Like Peptide 1; Infusions, Intravenous; Injections, Intraperitoneal; Lithium Chloride; Male; Neurons; Organ Specificity; Oxytocin; Peptide Fragments; Pituitary Hormones, Posterior; Prosencephalon; Protein Precursors; Proto-Oncogene Proteins c-fos; Vomiting | 2001 |
The care of the diabetic child in general practice.
Topics: Adipose Tissue; Adolescent; Atrophy; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Dietary Carbohydrates; Family Practice; Glucagon; Glycosuria; Humans; Hypoglycemia; Insulin; Ketones; Vomiting | 1977 |
The emergency management of the diabetic at home.
Topics: Diabetes Complications; Diabetes Mellitus; Diabetic Ketoacidosis; Emergencies; First Aid; Glucagon; Glucose; Home Nursing; Humans; Hyperglycemia; Hypoglycemia; Insulin; Vomiting | 1976 |
A model for treating post-irradiation nausea and vomiting in man: the action of insulin in abolishing radiation-induced delay in gastric emptying in the rat.
Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Gastric Emptying; Glucagon; Insulin; Male; Nausea; Radiotherapy; Rats; Vomiting | 1977 |
The optimal dose of glucagon: what is enough.
Topics: Colon; Digestive System; Duodenum; Glucagon; Humans; Injections, Intramuscular; Injections, Intravenous; Nausea; Radiography; Stomach; Time Factors; Vomiting | 1992 |
Combination of glucagon and low-dose metoclopramide in management of cisplatin-induced nausea and vomiting.
Topics: Cisplatin; Drug Therapy, Combination; Glucagon; Humans; Metoclopramide; Nausea; Vomiting | 1988 |
[Comparative study on the course of the complete insulin coma treatment in sugar or glucagon stimulation].
Topics: Adolescent; Adult; Body Weight; Child; Female; Fever; Glucagon; Glucose; Humans; Hypoglycemia; Insulin; Insulin Coma; Male; Seizures; Sex Factors; Time Factors; Vomiting | 1969 |
Use of glucagon in the treatment of acute diverticultis.
Topics: Adult; Aged; Constipation; Diarrhea; Diverticulitis, Colonic; Female; Gastrointestinal Motility; Glucagon; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Nausea; Vomiting | 1974 |
The hypocalcemic effect of glucagon in cases of hypercalcemia.
Topics: Feeding and Eating Disorders; Female; Glucagon; Humans; Hypercalcemia; Infant; Vitamin D; Vomiting | 1972 |
[Tyrosinosis. Primary and secondary biochemical changes].
Topics: Age Factors; Amino Acid Metabolism, Inborn Errors; Child, Preschool; Diet Therapy; Glucagon; Glucose; Humans; Hypoglycemia; Infant; Infant, Newborn; Liver Function Tests; Methionine; Phenylalanine; Phosphates; Protein Biosynthesis; Rickets; Statistics as Topic; Thrombocytopenia; Time Factors; Tyrosine; Vomiting | 1972 |
Haemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man.
Topics: Acute Disease; Aged; Blood Glucose; Blood Pressure; Cardiac Output; Cardiac Volume; Female; Glucagon; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nausea; Potassium; Pulmonary Circulation; Vascular Resistance; Vomiting | 1971 |